Product image of Linezolid Krka (Linezolid) supplied by GNH India

Linezolid Krka

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Krka (Linezolid)

Linezolid, the active ingredient in Linezolid Krka, is an oxazolidinone presented as an oral tablet for systemic use. It treats serious bacterial infections caused by resistant Gram‑positive organisms in both adult and pediatric patients.\n\nGNH India supplies Linezolid Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Linezolid is an antibacterial agent indicated for infections caused by resistant Gram‑positive bacteria.\n\nMethicillin‑resistant Staphylococcus aureus (MRSA) infections: provides effective bacterial eradication in skin, soft‑tissue and systemic disease.\nVancomycin‑resistant Enterococcus (VRE) infections: offers a therapeutic option when other agents fail.\nCommunity‑acquired pneumonia: treats pneumonia caused by susceptible pathogens.\nSkin and soft‑tissue infections: resolves cellulitis, abscesses and wound infections.\nComplicated intra‑abdominal infections: combats mixed aerobic and anaerobic organisms in the abdomen.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex and thereby halting translation. This action is bacteriostatic against most susceptible organisms and bactericidal at higher concentrations, targeting Gram‑positive pathogens including MRSA and VRE.

Side Effects

  • Linezolid may cause a range of adverse reactions, from mild to serious.\n\nCommon Side Effects:\n- Nausea: mild to moderate gastrointestinal upset.\n- Diarrhea: loose stools, often self‑limiting.\n- Headache: transient cranial discomfort.\n- Vomiting: occasional emesis.\n- Metallic taste: altered taste perception.\n\nSerious or Rare Side Effects:\n- Thrombocytopenia: significant drop in platelet count requiring monitoring.\n- Peripheral neuropathy: sensory changes with prolonged use.\n- Serotonin syndrome: risk when combined with serotonergic agents.\n- Lactic acidosis: rare metabolic disturbance.\n- Optic neuropathy: vision changes, may be irreversible.

Precautions & Warnings

  • Use of Linezolid requires careful clinical assessment and monitoring.\n\nRenal impairment: monitor renal function and adjust therapy as needed.\nHepatic impairment: assess liver enzymes before and during treatment.\nConcomitant serotonergic drugs: avoid due to risk of serotonin syndrome.\nProlonged therapy: perform regular complete blood counts to detect hematologic toxicity.\nPregnancy: safety unknown; use only if benefits outweigh risks.\nStore at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

  • Linezolid can interact with several drug classes, necessitating vigilance.\n\nMajor Interactions (Avoid):\n- Selective serotonin reuptake inhibitors (SSRIs): may precipitate serotonin syndrome.\n- Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive crisis and serotonin toxicity.\n- Tyramine‑rich foods: can cause hypertensive episodes when combined with linezolid.\n\nModerate Interactions (Monitor Closely):\n- Rifampin: induces metabolism, reducing linezolid plasma levels.\n- Warfarin: may enhance anticoagulant effect, requiring INR monitoring.\n- Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase bleeding risk, especially with thrombocytopenia.

Frequently Asked Questions

Linezolid Krka is indicated for infections caused by resistant Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA), vancomycin‑resistant Enterococcus (VRE), community‑acquired pneumonia, skin and soft‑tissue infections, and complicated intra‑abdominal infections.

Linezolid binds to the 50S subunit of bacterial ribosomes, blocking the formation of the initiation complex needed for protein synthesis. This inhibition stops bacterial growth and can lead to bacterial death, especially in susceptible Gram‑positive organisms.

The dosage of Linezolid Krka is determined by the prescribing clinician based on the specific infection, patient age, weight, renal and hepatic function, and other clinical factors. The prescriber will set the appropriate regimen.

The safety of Linezolid Krka in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and under close medical supervision.

To order Linezolid Krka, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Linezolid belongs to the oxazolidinone class and offers oral and intravenous options, unlike many alternatives that are only injectable. It is effective against MRSA and VRE where beta‑lactams and glycopeptides may fail, but it requires monitoring for hematologic and neurologic toxicity.

Linezolid Krka should be stored at ambient temperature, below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and discard any product that appears discoloured or damaged.

Linezolid Krka is administered orally as a tablet. It should be taken with or without food as directed by the prescriber, and the full course should be completed even if symptoms improve before the end of therapy.

Serious risks include thrombocytopenia, peripheral neuropathy, optic neuropathy, serotonin syndrome when combined with serotonergic agents, and rare cases of lactic acidosis. Patients should be monitored regularly for blood counts and neurologic symptoms.

Linezolid Krka should be avoided in patients with known hypersensitivity to linezolid or other oxazolidinones, those taking monoamine oxidase inhibitors, or individuals with uncontrolled hypertension who consume tyramine‑rich foods. Caution is also advised for patients with severe hepatic or renal impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT